Unravelling the complexity of cancer genomics and predisposition: nanopore sequencing and the potential for personalised care | Oxford Nanopore Technologies
- Targeted
- Cancer research
- Clinical research
- Human genomics
- Structural variation
- Gene fusions
October 17 2024
Transforming food safety with Oxford Nanopore sequencing
- Targeted
- Food safety
- Basecalling
- Nanopore Community
- Nanopore Community Meeting
- Whole genome
December 18 2024
Science unlocked: publication picks from September 2024 | Oxford Nanopore Technologies
- Targeted
- Adaptive sampling
- AMR
- Cancer research
- Clinical research
- Epigenetics
October 2 2024
Science unlocked: publication picks from October 2024 | Oxford Nanopore Technologies
- Targeted
- Human genomics
- Single cell
- Chromatin conformation
- Methylation
- Animal
November 5 2024
Science unlocked: publication picks from November 2024
- Targeted
- RNA
- AMR
- Infectious disease
- Human genomics
- Methylation
December 6 2024
Rapid identification of MSK-IMPACT cancer variants with real-time targeted nanopore sequencing
- Targeted
- Cancer research
- Adaptive sampling
- SNVs
- Structural variation
- PromethION
November 28 2024
Applying portable nanopore sequencing technology to the conservation of the critically endangered kākāpō
- Targeted
- Animal
- Whole genome
- MinION
- GridION
February 25 2022
Revealing hidden genetic variants in rare disease with nanopore sequencing
- Targeted
- Clinical research
- Variant calling
- Human genomics
- Structural variation
- Epigenetics
October 26 2023
Pushing the boundaries of rare disease research
- Targeted
- Clinical research
- Human genomics
- Whole genome
- PromethION
- MinION
June 6 2023
Multiomic single-cell cancer analysis — from mutation detection to understanding disease mechanisms
- Targeted
- Cancer research
- Clinical research
- Human genomics
- Single cell
- Transcriptome
February 13 2024
Highlights from NCM Houston | Oxford Nanopore Technologies
- Targeted
- Clinical research
- Human genomics
- Methylation
- MinION
- PromethION
December 7 2023
Challenging current gold-standard infectious disease diagnostic methods with full-length 16S sequencing | Oxford Nanopore Technologies
- Targeted
- 16S
- Bacteria
- Clinical research
- Identification
- Infectious disease
October 7 2024
At London Calling 2024, the Nanopore Community showcases how ‘nanopore sequencing can drive new discoveries in biology’
- Targeted
- Bacteria
- Cancer research
- Clinical research
- Conservation
- DNA
May 23 2024
Advancing Biopharma quality control: Oxford Nanopore Technologies at NCM Boston 2024
- Targeted
- Biopharma
- Supply chain monitoring
- Food safety
- Long-read
- Short-read
September 18 2024